EDGAR Filing Documents for 0000950103-23-004159

Form F-3 - Registration statement by foreign private issuers:

SEC Accession No. 0000950103-23-004159

Filing Date

2023-03-15

Accepted

2023-03-15 16:46:16

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM F-3	dp190410_f3.htm	F-3	511361
2	EXHIBIT 4.1	dp190410_ex0401.htm	EX-4.1	323321
3	EXHIBIT 4.2	dp190410_ex0402.htm	EX-4.2	372000
4	EXHIBIT 5.1	dp190410_ex0501.htm	EX-5.1	29026
5	EXHIBIT 5.2	dp190410_ex0502.htm	EX-5.2	17744
6	EXHIBIT 23.1	dp190410_ex2301.htm	EX-23.1	2080
7	EXHIBIT 107	dp190410_ex107.htm	EX-FILING FEES	50336
8	GRAPHIC	image_001.jpg	GRAPHIC	3611
9	GRAPHIC	image_002.jpg	GRAPHIC	4264
10	GRAPHIC	image_003.jpg	GRAPHIC	3607
11	GRAPHIC	image_004.jpg	GRAPHIC	1340
	Complete submission text file	0000950103-23-004159.txt		1325076

Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066

Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00

ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)